 clinical trials in South Carolina. The U.S. Food and Drug Administration is now recommending steps to expand drug and medical device trials in efforts to prioritize characteristics of patient population they aim to treat. The agency's suggestions to researchers include drafts on how to set goals for study enrollment separated by age group, ethnicity, sex and race and describe how they intend to meet those goals.